May 2 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2017 Mar 31, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 15 mln 29 mln 200 mln
(-48.0 pct) (+112.4 pct)
Operating loss 235 mln loss 182 mln loss 1.40
Recurring loss 241 mln loss 185 mln loss 1.40
Net loss 242 mln loss 186 mln loss 1.40
EPS loss 25.91 yen loss 20.28 yen loss 152.08 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T
((Tokyo Headline News Desk +813 6441 1812))